Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial - Concepedia

Concepedia

Publication | Open Access

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

DOI Full Paper Access

61

Citations

31

References

2024

Year

Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen, Pantelis Sarafidis, Katherine R. Tuttle, Christoph Wanner, Meike Brinker,

Nephrology Dialysis Transplantation

Abstract

FIND-CKD is the first phase 3 trial of finerenone in patients with CKD of non-diabetic aetiology.

References

	Year	Citations

Page 1